A 34-year-old man presented to the emergency department (ED) with left facial pain, pressure, and nasal congestion of several weeks' duration.
Oncologic staging using F18-FDG PET-CT revealed significant metabolic activity associated with the primary neoplasm in the maxillary sinus (see Figure 4 ). An enlarged ipsilateral level IIA lymph node in the neck with moderate metabolic activity (maximum standardized uptake value [SUV] 4.9) was demonstrated. Histopathologic study of this node revealed findings consistent with metastatic rhabdomyosarcoma. The PET-CT also demonstrated an osteolytic lesion in the ipsilateral left iliac bone with moderate hypermetabolism (maximum SUV 6.5) (see Follow-up PET-CT four weeks after initiation of chemotherapy showed a favorable early metabolic response at the site of the primary lesion (see Figure 6 ) as well as within the nodal and osseous metastatic foci (see Figure 7) . Repeat bone marrow cytology of the left iliac bone metastasis was repeated, with no malignant cells identified
Discussion
Although rhabdomyosarcoma is considered the most common pediatric solid tumor of the head and neck, it is a rare primary head/neck tumor in adult patients. imaging response to treatment of rhabdomyosarcoma has been documented in the literature in retrospective studies of pediatric patients. 5, 6 Although the imaging response to treatment has not been studied extensively in adult patients, the biologic behavior of rhabdomyosarcoma in the young adult has demonstrated similarity to pediatric cases in one retrospective series.
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Conclusion
In conclusion, this case report illustrates the potential of F18-FDG PET-CT in monitoring early response to chemotherapy. Findings of this case should prompt further investigation of the utility of PET-CT in predicting outcome and prognosis in adult patients with head/neck rhabdomyosarcoma following treatment. n
